Chemical Stock Jumps 10% After Receiving Approval for Its Fungicide Products

SYNOPSIS: India Pesticides Limited rose 10% after the company received EU Technical Equivalence approval for its fungicide product. The approval marks a key milestone in its global expansion strategy, supporting European market entry, export growth, and strengthening the company’s position in the international agrochemical sector.

The shares of a Small-Cap company specialising in the manufacturing of agrochemical technicals, formulations, and Active Pharmaceutical Ingredients (APIs), are in focus as they have rallied 10 percent in the day’s trade.

With a market capitalization of Rs. 1,876.01 crores in the day’s trade, the shares of India Pesticides jumped upto 10.1 percent, reaching a high of Rs. 171.95 per share compared to its previous closing price of Rs. 156.05 per share.

What Happened

India Pesticides Limited, engaged in the manufacturing of agrochemical technicals, formulations, and Active Pharmaceutical Ingredients (APIs), has received Technical Equivalence (TEQ) approval in the European Union (EU) for one of its fungicide products. The approval was granted on 29 May 2026 and marks an important milestone in the Company’s global growth strategy.

Strengthening International Presence

The approved fungicide product falls under the pesticides category and is intended for the international market. The approval will enable the Company to enhance its presence in the European market and expand its export opportunities.

Positive Impact on Business Growth

The Company expects this development to contribute positively to its export revenues and support higher foreign exchange earnings for the country. The approval further strengthens India Pesticides Limited’s position in the global agrochemical sector.

Market Expansion in the European Union

With this approval, the Company’s fungicide product will be introduced in the European Union market, supporting its long-term strategy of expanding its international footprint and increasing global business opportunities.

Financials & Others

The company’s revenue rose 28.59 percent, from Rs. 207 crore in Q4FY25 to Rs. 266 crore in Q4FY26. Meanwhile, the Net profit rose from Rs. 22 crores to Rs. 31 crores during the same period

The Company demonstrates strong financial efficiency with a Return on Capital Employed (ROCE) of 16.7% and a Return on Equity (ROE) of 12.6%, reflecting effective utilization of capital and shareholder funds. The low debt-to-equity ratio of 0.11 indicates a conservative capital structure with limited reliance on debt.

India Pesticides Limited (IPL) is an Indian agrochemical company established in 1984 and headquartered in Lucknow, Uttar Pradesh. The company manufactures a wide range of agrochemical products, including fungicides, herbicides, insecticides, and technical formulations, along with active pharmaceutical ingredients (APIs). It is known for its research-driven approach and supplies products to domestic and international markets.

It is an advanced molecule-based agrochemical manufacturing company supplying technicals and formulations to global clients. The company has a diversified product portfolio comprising 53 technicals and 52 formulations, supported by strong R&D capabilities with 2 R&D centres, 25 scientists, and EU Technical Equivalence (TEQ) certification.

The company operates through manufacturing facilities at Sandila (Hardoi) and Dewa Road (Lucknow), with a total installed capacity of approximately 38,200 MT, including 28,200 MT of technicals and 10,000 MT of formulations. Key product segments include herbicides and fungicides, with effective utilisation levels ranging between 67% and 100% across facilities.

India Pesticides has a strong global presence, exporting to 35+ countries and generating Rs. 408 Cr in export turnover. Its customer base is well diversified, with the top 10 customers contributing around 40% of revenue, reducing dependency risk.

For FY2026, India Pesticides’ revenue mix is primarily driven by Technical & API products, contributing 71% of total revenue, while Formulations account for the remaining 29%. Geographically, the company derives 61% of revenue from the domestic market and 39% from exports, reflecting a balanced presence across Indian and global markets.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Chemical Stock Jumps 10% After Receiving Approval for Its Fungicide Products appeared first on Trade Brains.